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Summary  
technique, differential display reverse transcription polymerase chain (DDRT-PCR), was 
the overall pattern of gene expression i  human articular knee chondrocytes induced by 
prototypical inducer of catabolic responses in degenerate joint diseases. One hundred 
ons generated approximately 10000 different PCR fragments for IL-I~ treated, as well as 
drocytes, cultivated in alginate beads. This represented 53% of all expressed chondrocyte 
~1 considerations. Side by side comparisons ofdifferential display patterns originating from 
yielded 44 reproducibly, differentially-displayed cDNA fragments, which were subcloned 
omology searches revealed sequence identities to the human ecrosis factor ~ (TNF-u) and 
, fibronectin, osteopontin, calnexin, and the DNA repair enzyme ERCC5. The differential 
vith Northern and quantitative PCR analyses. The known function of these genes and their 
indicate that the employed model system reflects the pleiotropic effects of IL-1 on the overall 
~rticular chondrocytes and identifies genes involved in very different biochemical pathways. 
ed sequence homologies to known genes and may represent novel genes. 
~play, Chondrocytes, IL-1, Osteoarthritis. 
Introduct ion 
~e ~xpression of specific genes is changed uring 
~urse  of degenerative joint diseases like osteo- 
~!d~ii~heumatoid arthritis [1]. Those genes include 
~!!:matrix-degrading matrix metalloproteinases 
Ps), which are upregulated uring degrada- 
~i-~ ' processes [2] and the structural matrix 
~ponents  like the aggreean core protein, which 
dow regulated r3]. 
The differential expression of various early and 
responsive genes including c-fos, c-jun, junB 
metallothionin [4] suggests that changes in 
~e expression affect a multitude of disease 
~e~g~latory and metabolic pathways 
.~n our study, we wanted to test the usefulness 
~the  mRNA fingerprinting technique of differ- 
~t ia l  displa reverse transcription polymerase Y 
Chain reaction (DDRT-PCR) to detect changes not 
~ ly  in the expression of specific, single genes 
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but changes in the overall gene expression, 
reflecting the pleiotropic action of the cytokine 
interleukin-1 (IL-1) on various metabolic processes. 
DDRT-PCR was originally described by Liang 
and Pardee [5] and further refined by Liang et al. 
[6] and Bauer et al. [7]. This new tool promises 
access to low abundant ranscripts, which are 
difficult to detect with conventional subtractive 
hybridization studies, and it permits the simul- 
taneous identification of both up- and down- 
regulated genes. 
In order to gain an understanding of ethiopatho- 
logical processes leading to cartilage degradation, 
~the most direct approach would be a comparison 
between the gene expression pattern in macro- 
scopically intact versus osteoarthritic artilage. 
But such studies would also resolve patient 
specific differences in the expression of genes, 
which could potentially conceal disease relevant 
changes in gene expression. This lead us to start 
differential gene expression studies with a practi- 
cable model system comparing the gene expression 
in IL-I~ stimulated and unstimulated, cultured 
human articular knee chondrocytes obtained from 
joint replacement surgery. 
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The most important reasons for choosing IL-I~ 
as the mediator were that it acts on many 
connective tissue cell types, and that IL-1 is the 
prototypical inducer of catabolic responses in 
chondrocytes [8]. It stimulates expression of 
proteases, including MMPs [9], leading to degra- 
dation and release of proteoglycans (PGs) 
[3, 10, 11], induces an increase of the constitutive 
hsp70 [12], of IL-8 [13], COX-2 and PLA2 [14] mRNA. 
In addition, IL-1 suppresses c~1 type II procollagen 
expression [15] and it inhibits synthesis in 
chondrocytes [3, 10, 16-19]. The net result of IL-1 
treatment of cartilage tissue in vitro [12, 20], or the 
injection of IL-1 into the synovial cavity [21, 22], is 
loss of cartilage matrix by a .~combination of 
excessive catabolism and inadequate anabolism of 
matrix macromolecules for tissue repair. These 
results and the presence of IL-1, PG fragments and 
proteolytic enzymes in inflamed joints [23-25], 
point to an important role for IL-1 in cartilage 
degradation in rheumatoid arthritis and during 
inflammatory episodes in osteoarthritis. 
Quantitative PCR served to validate our model 
system by detecting an IL-I~ mediated upregula- 
tion of MMP-3 message. To optimize reproducibil- 
ity and sensitivity of our chondrocyte gene 
expression analysis, we employed in parallel the 
large number of 100 different primer combinations 
for DDRT-PCR on chondrocytes originating from 
two different issue donors. Thus, we were able to 
detect 44 reproducibly, differentially-expressed 
cDNA fragments. Subsequent cloning and se- 
quence analysis revealed the identity of some 
cDNAs to known genes, including fibronectin and 
TSG-6, already known to be upregulated by IL-1. 
The identification of these genes allows interest- 
ing speculations on the specific role of these genes 
in the IL-I~ mediated chondrocyte metabolism. In 
addition, this approach may eventually enable the 
identification of new target molecules for drug 
intervention and candidate genes to monitor 
chondrocyte metabolism during clinical studies of 
degenerative joint diseases. 
Mater ia l s  and  Methods  
EXPERIMENTAL  PROCEDURES 
Cell culture 
u Articular knee cartilage specimens were ob- 
tained from four different issue donors (donor A: 
male 65-years old, donor B: female 73-years old, 
donor C: female 6O-years old, and donor D: female 
63-years old) undergoing total joint replacement 
surgery for osteoarthritis. None of these individ- 
uals had received treatment by radiation or  
chemotherapy. After surgery, articular carti. :~ 
lage slices were aseptically dissected from both 
femoral condyles, tibia plateaus and patellae and 
subjected to sequential enzymatic digestion with 
pronase (Boehringer Mannheim) and collagenase 
(Worthington) according to H~uselmann et al. [26]. 
Released chondrocytes were suspended in sterile 
0.15M NaC1 containing 1.25% low viscosit~ 
alginate (FMC BioProducts) at a concentration o9 
4×108 cells/ml, and squeezed through a 22 gauge 
needle into 102 mM CaCI2 solution to form cel~ 
entrapping spherical beads containing an average 
number of 44 ± 2x103 chondrocytes. A totaI 
number of 2×.i07. cells were maintained in 50/54 
HAMS' F12/DMEM (Life Technologies), sup! 
plemented with 10% heat inactivated fetal calf 
serum (Sigma), 25 ~tg/ml ascorbic acid (Sigma) andi 
50~g/ml gefftamycin (Life Technologies) in 
humidified atmpsphere of 5% CO2 at 37°C. Cultures 
were allowed ~o recover for 3 days with daily 
[ 
medium changes?:Then, the beads were subdivide~ 
into two populati(~ns for further 3 days of culture 
in the presence or absence of 50 pg/ml recombinant 
human IL-I~ (Genzyme). To release chondrocytes 
from alginate, beads were dissolved in dissolution 
buffer containing 55ram sodium citrate, 3OmM 
EDTA and 0.15M NaC1 and placed at room 
temperature for 10min. Viability of cells was 
checked by eosin-red exclusion. 
Primer syntheses 
Arbitrary oligodecamer primers 1-10 and degen- 
erate anchored oligo-dT primers (T12MN) were 
synthesized using the 392 DNA synthesizer 
(Applied Biosystems) and purified by denaturing 
polyacrylamide gel electrophoresis. Some oligode- 
camer primers, 11-25, were purchased from 
Biometra. All employed primers are shown in 
Table I. 
RNA isolation and first strand cDNA synthesis 
Total RNA from cultured human articular 
chondrocytes was prepared according to the acid 
guanidinium-isothiocyanate phenol-chloroform 
method [27] and incubated with 10 U RNase free 
DNase I (Life Technologies) in 20 mM Tris-HCl~ 
(pH 8.3), 50 mM KC1 and 2.5 mm MgC12 for 30 rain at: 
37°C to remove any residual chromosomal DNA! 
contamination. After extraction with phenol-chlo 
roform (3:1), the supernatant was ethanol precipi -~ 
tated in the presence of 0.3 M NaOAc (pH 5.2): 
and the RNA was finally redissolved in diethyi 
pyrocarbonate reated water. Integrity of the RN~ 
Osteoarthr i t i s  and Carti lage Vol. 5, No. 2 131 
,~arose gels. Total 
ribed using 200 U 
;e (Life Technol- 
containing 50 mM 
nM dithiothreitol, 
P, dTTP, dCTP, 
RNase Inhibitor 
.5 ~AM degenerate 
• Reactions were 
for 5min. For 
NA synthesis was 
~ue donor D using 
er Mannheim). 
~[ff~.e:~ial display 
~pIi~e:d in a DNA thermal cycler 
~e l  480) in 20 pl reactions 
~i:~i~'  of the original T~2MN-primer 
~:nthesis n combination with 0.5 pM 
~: i i~r~am primer, dNTP mix (dGTP, 
each, 10pCi u-[3~S]dATP 
U4 
u5 
~U8 
~o 
U~2 
LT13 
U14 
U15 
U16 
U17 
U18 
U19 
U20 
U21 
U22 
U23 
U24 
U25 
Table I 
go dT-primers 
oligodecamer- 
I'-PCR 
[T~2MN] 
]~TTTMA 
]?TTTMT 
]~TTTMG 
]~TTTMC 
~rs 
AC 
5 ' -GAAACGGGTG 
5 ' -GTGACGGGTG 
5 ' -GCGTAACGCC 
5 ' -GTGATCGCAG 
5 ' -AGCCAGCGAA 
5 ' -GACCGCTTGT 
5 ' -AGGTGACCGT 
5 ' -CAAACGTCGG 
5 ' -GTTGCGATCC 
5 ' -TACAACGAGG 
5 ' -TGGATTGGTC 
5 ' -CTTTCTACCC 
5 ' -TTTTGGCTCC 
5 ' -GGAACCAATC 
5 ' -AAACTCCGTC 
5 ' -TCGATACAGG 
5 ' -TGGTAAAGGG 
5 ' -TCGGTCATAG 
5 ' -GGTACTAAGG 
5 ' -TACCTAAGCG 
5 ' -CTGCTTGATG 
5 ' -GTTTTCGCAG 
5 ' -GATCAAGTCC 
5 ' -GATCCAGTAC 
(1000 Ci/mmol, 10 mCi/ml; Amersham), 10 mM Tris- 
HC1 (pH 8.3), 50raM KC1, 1.5m~ MgC12, 0.001% 
gelatin and 2.5U AmpliTaq DNA polymerase 
(Perkin Elmer). Light mineral oil was overlaid and 
thermal cycling was performed as follows: 30 s of 
denaturation at 94°C, 2 min of annealing at 40°C, 
30 s of extension at 72°C for 40 cycles followed by 
5 rain postextension at 72°C. For gel electrophor- 
esis, each PCR product was mixed with 5 pl dye 
solution (95% formamide, 20mM EDTA, 0.05% 
bromphenolblue and 0.05% xylenecyanol FF), 
denatured at 95°C for 2 min and quenched on ice. 
Each sample (6 pl) was loaded on a 6% acrylamide/ 
7M urea gel (35x43×0.4 cm). For detection of 
radiolabeled PCR fragments, gels were transferred 
to blotting paper without acetic acid-methanol 
fixation; dried gels were exposed to X-ray film 
(Kodak X-OMAT) for 48 h. 
Elution and reamplification of cDNAs 
Careful side by side comparisons of band 
patterns identified those PCR fragments that 
appeared ifferentially expressed. Those were cut 
from acrylamide gels, transferred into eppendorf 
tubes and rehydrated for 10 min with 100 pl 10 mM 
Tris-HC1 (pH 7.5), I mM EDTA at room tempera- 
ture. After boiling the gel slices for 15 min, PCR 
fragments were recovered by ethanol precipitation 
in the presence of 0.3 M NaOAc and 20 pg glycogen 
(Boehringer Mannheim) as a carrier and redis- 
solved in 10 pt sterile water. Five microliters of this 
volume was used for reamplification by PCR using 
appropriate primers and conditions as described 
above except for dNTP concentration at 20 ~tM and 
omission of radioisotopes. Reamplified cDNAs 
were visualized by electrophoresis ona 2% agarose 
gel, cut out and eluted from the gel matrix by 
ultrafi ltration using spin columns (Millipore). 
Purified cDNAs were then either used for cloning 
or as probes for Northern-blot analysis. 
Cloning and sequencing of cDNAs 
Reamplified cDNA probes were cloned into the 
pCRII-vector using the TA cloning system (Invitro- 
gen). Plasmid DNA sequencing of subcloned 
cDNAs with either Sp6 or T7 primer was carried 
out on both strands using sequenase 2.0 sequenc- 
ing kit (USB). 
DNA sequence analysis 
Searching for homology between subcloned 
cDNAs and sequences already listed in one of the 
DNA databases (GenBank release 91, DDBJ and 
EMBL database) was performed using the FASTA 
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program developed by Pearson and Lipman [28] 
included in the GCG software package (Genetics 
Computer Group, Madison, U.S.A.). Alternatively, 
a newer program for rapid similarity searches was 
applied [29] using the Basic Local Alignment 
Search Tool (BLAST) at NCBI (National Center 
for Biotechnology Information). 
Quantitat ive PCR 
For quantitative PCR, a 598 bp internal standard 
containing gene specific primer sites for MMP-3 
(5'-CACTTCAGAACCTTTCCTGGCATC-3' and 5'- 
GCTTCAGTGTTGGCTGAGTG-3', corresponding 
to nts 338-361 and 725-744) and a 596 bp internal 
standard containing gene specific primer sites for 
TSG-6 (5'-GGTGTGTACCACAGAGAAGCA-3' and 
5'-GGGTTGTAGCAATAGGCATCC-3', correspond- 
ing to nts 174-194 and 437-457) was constructed 
using the PCR-MIMIC kit (Clontech). Then, serial 
dilutions of the internal MMP-3 standard (fivefold 
dilutions from 1000-1.6 attomol) respectively of the 
internal TSG-6 standard (twofold dilutions from 
0.5-0.016 attomol) were added to the PCR reactions 
containing constant amounts of cDNA reverse 
transcribed from 20 ng of total RNA from either 
stimulated or not stimulated cells as described 
above. PCR was performed in 50 ~l reactions in lx 
PCR-buffer (10 mM Tris-HC1 at pH 8.3, 50 mM KC1, 
1.5mM MgC12 and 0.001% gelatin) with 200 ~tM 
dNTP mix, 0.4 ~tM primer and 2.5 U AmpliTaq DNA 
polymerase (Perkin Elmer). Thermal cycling was 
performed as follows: 30 s of denaturation at 94°C, 
30 s of annealing at 60°C and 45 s of extension at 
72°C for 25 cycles. Ten microliters of each PCR 
tube was separated on a 2% agarose/ethidium 
bromide gel and fluorescence was quantified by com- 
puter imaging using BioImage software (Millipore) 
to calculate the relative amounts of target and 
standard-DNA. The logarithm of the ratios of the 
two products were then plotted after correcting for 
the difference in size between them as a func- 
tion of the log of the initial amount of standard- 
DNA added to each reaction to calculate the point 
of equimolarity of standard and target DNA. 
Northern-blot analysis 
Isolation of RNA from cultured chondrocytes 
used for Northern-blot analysis was performed 
exactly as described above. For gel separation, 
10 ~tg of total RNA were denatured by heating at 
65°C for 10 min in a solution of 50% formamide, 
20 mM MOPS and 2.2 M formaldehyde, separated 
through 1% agarose containing 2.2M formal- 
dehyde and transfered to  a positively charged 
nylon membrane (Amersham) by standard capil- 
lary blotting procedures [30]. After U.V. cross. 
linking, the blots were prehybridized for 1 h in 
rapid-hyb-buffer (Amersham) at 65°C. The follow- 
ing probes, obtained by reverse transcription 
(RT)-PCR from human articular chondrocytes, 
were radiolabeled for hybridization with ~- 
p2P]dCTP (3000 Ci/mmol, 10 mCi/ml; Amersham) 
using random nonamer primers (Amersham): A 
330bp cDNA corresponding to nts 61-390 from 
human osteopontin cDNA (GenBank J04765), 
340 bp cDNA corresponding to nts 881-1220 from 
human calnexin (GenBank M94859), a 289bp~ 
cDNA corresponding to nts 4292-4580 from human: 
fibronectin. (GenBank X02761), a 226bp cDNA i 
corresponding to ,~ nts 597-822 from human TSG-6 
(GenBank M31165) and a 263 bp cDNA correspond-' 
ing to nts 3097-3359 from human ERCC5 (GenBanki 
Dt6305). After h~bridization for 2 h at 65°C the b]o~ 
was subsequently~' washed in 2xSSC, 0.1% SDS at 
37°C for 15min "0xSSC: 0.15M NaCI, 0.015~ 
sodium citrate, pH 7~0), followed by two sucessive 
washes with 1 x SSC,~.I% SDS at 65°C for 10 min- 
respectively. If necessary, a final high stringency 
wash was performed with 0.1xSSC, 0.1% SDS at 
65°C for 15 min. The b l~s  were then analyzed by 
autoradiography using Kodak X-Omat films a~ 
-80°C with intensifying s~reens for 2-7 days and 
intensity of bands was quantified with a phospho- 
rimager (Biorad). All blots were stripped with 
boiling 0.5% SDS solution and reprobed with 
labeled murine [~-actin cDNA (Clontech) to 
demonstrate qual loading of RNA in each lane.  
Resul ts  and D iscuss ion  
THE USED MODEL SYSTEM AND ITS VAL IDAT ION 
To detect IL-I~ mediated changes in the overall 
gene expression potentially reflecting processes 
connected with cartilage degradation, we com- 
pared the mRNA profile • of human articular knee 
chondrocytes treated with and without IL-I~. For 
this, human knee cartilage from joint replacemen~ 
surgery was enzymatically digested to yield 
approximately 3-5 x 106 chondrocytes/g of cartilage 
tissue. Embedded in alginate, human art icul~ 
chondrocytes maintain their differentiated pheno~ 
type [26] and show almost identical behavior to 
cartilage slice cultures when treated with IL-I~I:: 
We, therefore, chose the alginate embedding andl 
culture conditions as given by H~iuselmann et al( ~: 
[31]. For the choice of the employed IL-I~ 
concentration of 50 pg/ml we were guided by the 
finding that this concentration leads to a 85°~ 
inhibition of 3SS-sulfate incorporation into PG 
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16g [standard] m attomol 
~of  ~he results of quantitative PCR 
~er~ine MMP-3 (a) and TSG-6 (b) 
lev~!s from chondrocytes ofdonor D. 
o~o~ amplified target to standard 
~ ~ diiSufiction of the log of the known 
~.~iiia~d~d to the PCR reaction. 
ared with untreated 
~y the in vivo concen- 
~vial fluids of patients 
ranges from 20-128 pg/ 
to 2 × 107 chondrocytes, 
[vided into two popu- 
with 50 pg/ml recombi- 
L, while the other was 
edium without IL-I~, 
mderwent DDRT-PCR 
3onsiveness of alginate 
our model system, we 
the relative amount of MMP-3 tran- 
~oth cell populations. Because IL-1 is 
~timulate the expression of MMP-3 in 
ective tissue cells, including synovio- 
chondrocytes [22, 33], this criterium 
~ce to provide the basis for our 
display analysis. To quantify MMP-3 
Ldy-state level, quantitative, competi- 
~PCR) using an internal standard was 
¢~ployed [34]. Fig. l(a) shows the log of the ratios 
of the PCR products specific for MMP-3 and the 
standard-DNA graphed as a function of the initial 
amount of standard-DNA added to the PCR 
reactions for the determination of the point of 
equimolarity. Using this approach, we determined 
in three independent experiments 4827 ± 792 
(N= 3) MMP-3 mRNA molecules/pg of total RNA 
for unstimulated chondrocytes, and 17,188 ± 2066 
(N= 3) mRNA molecules per pg of total RNA for 
IL-I~ stimulated chondrocytes, an upregulation by 
a factor of 3.6. Thus, chondrocytes cult ivated in 
alginate from patients with osteoarthrit is undergo- 
ing joint replacement surgery, do indeed respond 
to IL-I~ with an upregulation of MMP-3 message. 
DIFFERENTIAL DISPLAY ANALYSIS 
A total of 2 x 107 chondrocytes released from the 
alginate beads yielded 40 ~g total RNA, which was 
subsequently subjected to DDRT-PCR analysis. 
Because our goal was to detect changes in the 
overall gene expression, we wanted to resolve as 
many differentially expressed genes as possible 
and thus employed the large number of 100 
different primer combinations in order to increase 
our chances to detect weaker expressed genes. The 
used primer combinations comprised four different 
degenerate 3'oligo tiT-primers and 25 different 
5'oligodecamer p imers, as given in Table 1. They 
resolved a total of approximately 10 000 cDNAs on 
high resolution acrylamide gels for each cell popu- 
lation analyzed. According to theoretical calcu- 
lations [35] this amount and length of primers 
should represent 53% of all expressed cellular 
genes. Fig. 2 shows some examples of differential 
displays resolving approximately 80-120 cDNA 
fragments per single lane. The visual side by side 
comparison between lanes resolving cDNA frag- 
ments generated from IL-I~ stimulated versus 
unstimulated chondrocytes identified a total of 
123 recognizable differentially displayed cDNA 
fragments. 
To address the reproducibil ity and the major 
drawback of DDRT-PCR, its 'noise level' of false 
positives [6], five primer pairs were used repeatedly 
in initial experiments on the same cDNA prep- 
aration. Although some minor variances were 
seen, probably due to the noise level of DDRT-PCR, 
most bands were reproducibly displayed. Primer 
combinations differed to some extent in their 
ability to yield similar overall band patterns (see 
Fig. 3 and note differences in reproducibil ity 
between primer pairs I and II). Because we 
expected that patient specific differences and 
polymorphisms in gene products would influence 
DDRT-PCR results more than PCR reproducibil ity, 
we validated our differentially displayed fragments 
stringently by applying the same 100 primer 
combinations to RNA originating from a second 
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tissue donor. Fig. 3 compares the DDRT-PCR 
analysis with two different primer pairs on the 
RNA from two different issue donors. All possible 
combinations of bands can be seen: bands occuring 
in all lanes, irrespective of both IL-I~ stimulation 
Primer pair 
A B C D E F G 
IL-I~ stimulation 
- -+  - -4 .  - -+  - -+ - -+ - -+ - -4 -  
and tissue donor; bands appearing irrespective of 
stimulation, but specific for one of the two donors; 
IL-I[~ dependent differentially displayed ~ bands 
specific for one donor, but not for the other donor; 
and finally bands, which were differentially and 
reproducibly displayed by using RNA from the two 
different donors. Of the latter, we identified a total 
of 52 bands eliminating 71 bands from our initial 
screen. Of the 52 bands, 68% arose from IL-I~ 
stimulated chondrocytes. As seen in Fig. 3 (arrows), 
candidate bands differ in .their signal intensities. 
The differentially displayed band in Fig. 3(a) and 
(b) is much stronger upregulated by IL-I~, than the 
differential band in Fig. 3(c) and (d). This may 
reflect cellular mRNA :levels or it is based on the 
nonquantitative nature of the PCR amplification 
process itself. The size of the 52 differentially 
displayed cDNA fragments varied from 175-600 bp, 
with an average size of approximately 300 bp. 
Forty-four of the initial 52 fragments were 
subcloned into the TA cloning vector pCRII and 
sequenced. Fig. 4 depicts the differentially dis- 
played bands later identified to correspond to 
TSG-6, fibronectin, osteopontin and calnexin. 
GENES IDENTI f iED THROUGH HOMOLOGY SEARCHES 
AND THEIR  POTENTIAL  ROL~E IN  IL-lfl MEDIATED 
PROCESSES 
Sequence homology searches revealed that 27 
sequences did not match with sequences in the 
data bases and thus could represent new genes. 
Nine sequences matched expressed sequence tags 
(ESTs), gene fragments identified in human 
genome sequencing projects without functional 
assignments. Five sequences showed identity with 
the following known human genes (GenBank 
accession umber and our clone identifier given i
brackets): fibronectin (X02761, TTO20/1); ). TSG-6: 
tumour necrosis factor (TNF)-stimulated gene-6 
(M31t65, TAU7/2); osteopontin (J04765, TAU1/1); 
calnexin (M94859, TTU2/2) and ERCC5 (D16305, 
TTO16/2). 
The known functions of these genes and their 
known IL-1 responsivness, reproduced in our 
FIG. 2. Examples of differential displays for the detection 
of IL-I~ induced changes in overall gene expression 
patterns in human articular knee chondrocytes culti- 
vated in alginate beads. Total RNA derived from 
chondrocytes of donor B stimulated for 72 h with IL-I~ (+) 
and RNA from not stimulated cells (-) was subjected to 
DDRT-PCR using following primer combinations: 
A = T12MG and U22; B = T12MG and U23; C = T12MG and 
U24; D = T12MG and U25; E = T~2MC and U22; F = T~2MC 
and U24; G = T12MC and U25. Examples of differentially 
expressed cDNAs which could be reproduced using RNA 
from donor A are denoted with asterisks. 
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Primer pair I Primer pair II 
Donor Donor Donor Donor 
:A  B A B 
~LI~ IL-I~ IL-I~ IL-I~ 
~ifferential display analysis as in Fig. 2 using two 
nt primer ' combinations (I=T,2MC and U23; 
~and U24) to reveal individual differences 
~:: th~ ~ Ilt induced gene expression pattern between 
~; :~f fe rent  tissue donors (donor A and donor B). 
~eads denote reproducibly, d{fferentially dis- 
~{~ye~ cDNA fragments. See results for further details. 
~de l  system, argue that our model system 
i i~t i - f ied  a multitude of genes directly or 
~ndirectly involved in the context of cytokine 
:induced loss of cartilage matrix. 
Fibronectin, a glycoprotein involved in cell- 
matrix interactions, is present at low levels in the 
extracellular matrix of normal cartilage [36], but 
gets accumulated in the sy~iovial fluid and the 
inflamed synovial and pannus urfaces of the knee 
joints in rheumatoid arthritis, and to a lesser 
degree in osteoarthritis patients [37, 38]. Intra- 
articular injection of fibronectin fragments causes 
a severe depletion of cartilage PGs in vivo [39], 
which is explained by the induced release of 
several proteinases, including MMP-3 [40]. There- 
fore, upregulation of fibronectin by IL-I~ in our 
model system can be seen as a positive feedback 
regulation, enhancing the self-destructive poten- 
tial of chondrocytes. 
TSG-6, a TNF and/or IL-1 induced, secretory 
39kDa glycoprotein with extensive sequence 
homology with a region implicated in hyaluronate 
binding [41], was detected by Wisniewski et al. [42] 
in high levels in synovial fluids of patients with 
various forms of arthritis, while synovial fluid, 
obtained from persons without known joint 
disease, did not contain any detectable TSG-6 
protein. The local source for TSG-6 in the joint 
cavity are synoviocytes [42] and articular chondro- 
cytes [43]. 
Using quantitative PCR, as described above, on 
chondrocytes from tissue donor D [Fig. l(b)], we 
were able to determine 1.56 + 0.26 (N=2) TSG-6 
mRNA molecules/pg oftotal RNA for unstimulated 
- -  + 
IL-I[~ stimulation 
- + - + - + 
TSG-6 Fibronectin Osteopontin Calnexin 
FIG. 4. Parts of differential displays containing bands 
identified as: cDNA fragments coding for TSG-6, 
fibronectin, osteopontin and calnexin. Arrowheads 
denote fragments originating from IL-I~ treated (+) or 
untreated (-) human articular knee chondrocytes. 
Primer pairs used: H =T12MA and U17; I= T12MT and 
U10; J=TI2MA and Ull; K=T12MT and U12. 
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human articular chondrocytes cultured in alginate 
beads, and 9.29 ± 1.94 (N= 2) molecules/pg of total 
RNA in IL-I~ stimulated cells. Thus IL-I~ 
upregulated TSG-6 mRNA steady state level by a 
factor of 5.9. 
TSG-6 forms complexes with the serine protease 
inhibitor inter-u-inhibitor [44]. This complex 
inhibits plasmin and could interfere with the acti- 
vation cascade of proMMPs. This may correspond 
with the experimental finding, that recombinant 
human TSG-6 exerts potent anti-inflammatory 
activity in the murine air pouch model of inflam- 
mation elicited by carrageenan or IL-1 [45]. 
ERCC5, the human homolog to yeast RAD2 [46], 
is a component of the excision nuclease complex 
involved in mammalian DNA excision repair [47]. 
Although we do not yet understand the direct link 
between the upregulation of ERCC5 and matrix 
degradation, the finding of this gene may indicate 
the wide scope of cytokine influenced cellular 
processes. 
For osteopontin, a sialophosphoprotein mediat- 
ing cell-matrix and cell-cell interactions [48], 
several reports document a IL-1, TNF and 
lipopolysaccharide (LPS) inducible expression of 
osteopontin in epidermal cells, bone cells and 
osteoblasts [49], whereas constitutive expression 
was observed in kidney and placenta [50]. Hwang 
et al. [51] reported, that osteopontin suppresses the 
induction of inducible nitric oxide synthase (iNOS) 
activity by LPS, probably at the level of induction 
of iNOS gene expression. This indicates a role for 
osteopontin as a general modulator of nitric oxide 
synthesis. Large amounts of NO are produced in 
human articular chondrocytes in alginate culture 
in response to IL-1 [31]. NO also plays a regulatory 
role in the activation of MMPs [52]. Our finding 
that IL-I~ mediates downregulation of osteopontin 
may thus point to a compensatory mechanism, 
which would allow upregulation of iNOS, in- 
creased production of NO and thus PG degra- 
dation. 
Calnexin is an endoplasmic reticulum (ER) 
resident chaperone, which binds to incorrectly or 
incompletely folded glycoproteins [53] and thus 
retains them in the ER [54]. IL-1 downregulates the 
expression of PGs in chondrocytes [3, 17, 18], 
probably by inhibiting the protein core sythesis 
[16]. Therefore, we speculate, that the IL-I~ 
induced downregulation of calnexin mRNA steady 
state level reflects a downregulation of the total 
chondrocytic PG biosynthesis pathway, including 
the quality control system of the ER. 
The upregulation of TSG-6 and fibronectin and 
the downregulation of osteopontin and calnexin 
mRNA steady state l vel was verified by Northern 
1.4 kb 
TNF-st imulated gene 6 
0% 100% 
7.7 kb 
Fibronectin 
63% 100% 
5 .3kb  
Fibronectin 
56% 100% 
1.8 kb 
Osteopontin 
100% 21% 
~,8 kb 
~hlnexin 
100% 60% 
2.0 kb 
Actin 
100% 99% 
- -  + 
IL-I[3 
FIG. 5. Northern blot hybridization a alysis of total RNA 
of human articular knee chondrocytes from donor C 
cultivated in alginate beads with (+) and without IL-I~ 
(-) stimulation, probed with TSG-6, fibronectin, osteo- 
pontin, calnexin, and ~-actin cDNA. The expected sizes 
of mRNAs are given. A phosphorimager quantification 
determined the relative amounts of messages (given 
in %). 
analyses using total RNA from IL-I~ stimulated 
and unstimulated chondrocytes originating from 
tissue donor C. As seen in Fig. 5, all messages were 
found differentially expressed. TSG-6 expression 
was detected only in IL-I~ stimulated chondro- 
cytes. A phosphorimager quantification revealed 
an IL-I~ induced upregulation of fibronectin full 
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